Global Immuno-oncology Therapy Market Research Report 2026(Status and Outlook)
Immuno-oncology therapy is a type of cancer treatment that harnesses the body"s immune system to target and destroy cancer cells. It includes therapies such as immune checkpoint inhibitors, cancer vaccines, and adoptive T cell therapies.
The global Immuno-oncology Therapy market size was estimated at USD 1317.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Immuno-oncology Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Immuno-oncology Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Immuno-oncology Therapy market.
Global Immuno-oncology Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co., Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics
Market Segmentation (by Type)
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Market Segmentation (by Application)
Hospitals
Ambulatory Surgical Center
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Immuno-oncology Therapy Market
Overview of the regional outlook of the Immuno-oncology Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno-oncology Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Immuno-oncology Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Immuno-oncology Therapy market size was estimated at USD 1317.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Immuno-oncology Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Immuno-oncology Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Immuno-oncology Therapy market.
Global Immuno-oncology Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co., Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics
Market Segmentation (by Type)
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Market Segmentation (by Application)
Hospitals
Ambulatory Surgical Center
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Immuno-oncology Therapy Market
Overview of the regional outlook of the Immuno-oncology Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno-oncology Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Immuno-oncology Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Immuno-oncology Therapy
1.2 Key Market Segments
1.2.1 Immuno-oncology Therapy Segment by Type
1.2.2 Immuno-oncology Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 IMMUNO-ONCOLOGY THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Immuno-oncology Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Immuno-oncology Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 IMMUNO-ONCOLOGY THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Immuno-oncology Therapy Product Life Cycle
3.3 Global Immuno-oncology Therapy Sales by Manufacturers (2020-2025)
3.4 Global Immuno-oncology Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Immuno-oncology Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Immuno-oncology Therapy Market Competitive Situation and Trends
3.8.1 Immuno-oncology Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Immuno-oncology Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 IMMUNO-ONCOLOGY THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Immuno-oncology Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF IMMUNO-ONCOLOGY THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Immuno-oncology Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Immuno-oncology Therapy Market
5.7 ESG Ratings of Leading Companies
6 IMMUNO-ONCOLOGY THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno-oncology Therapy Sales Market Share by Type (2020-2025)
6.3 Global Immuno-oncology Therapy Market Size by Type (2020-2025)
6.4 Global Immuno-oncology Therapy Price by Type (2020-2025)
7 IMMUNO-ONCOLOGY THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno-oncology Therapy Market Sales by Application (2020-2025)
7.3 Global Immuno-oncology Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Immuno-oncology Therapy Sales Growth Rate by Application (2020-2025)
8 IMMUNO-ONCOLOGY THERAPY MARKET SALES BY REGION
8.1 Global Immuno-oncology Therapy Sales by Region
8.1.1 Global Immuno-oncology Therapy Sales by Region
8.1.2 Global Immuno-oncology Therapy Sales Market Share by Region
8.2 Global Immuno-oncology Therapy Market Size by Region
8.2.1 Global Immuno-oncology Therapy Market Size by Region
8.2.2 Global Immuno-oncology Therapy Market Size by Region
8.3 North America
8.3.1 North America Immuno-oncology Therapy Sales by Country
8.3.2 North America Immuno-oncology Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Immuno-oncology Therapy Sales by Country
8.4.2 Europe Immuno-oncology Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Immuno-oncology Therapy Sales by Region
8.5.2 Asia Pacific Immuno-oncology Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Immuno-oncology Therapy Sales by Country
8.6.2 South America Immuno-oncology Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Immuno-oncology Therapy Sales by Region
8.7.2 Middle East and Africa Immuno-oncology Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 IMMUNO-ONCOLOGY THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Immuno-oncology Therapy by Region(2020-2025)
9.2 Global Immuno-oncology Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Immuno-oncology Therapy Production
9.4.1 North America Immuno-oncology Therapy Production Growth Rate (2020-2025)
9.4.2 North America Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Immuno-oncology Therapy Production
9.5.1 Europe Immuno-oncology Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Immuno-oncology Therapy Production (2020-2025)
9.6.1 Japan Immuno-oncology Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Immuno-oncology Therapy Production (2020-2025)
9.7.1 China Immuno-oncology Therapy Production Growth Rate (2020-2025)
9.7.2 China Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Amgen
10.1.1 Amgen Basic Information
10.1.2 Amgen Immuno-oncology Therapy Product Overview
10.1.3 Amgen Immuno-oncology Therapy Product Market Performance
10.1.4 Amgen Business Overview
10.1.5 Amgen SWOT Analysis
10.1.6 Amgen Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Basic Information
10.2.2 AstraZeneca Immuno-oncology Therapy Product Overview
10.2.3 AstraZeneca Immuno-oncology Therapy Product Market Performance
10.2.4 AstraZeneca Business Overview
10.2.5 AstraZeneca SWOT Analysis
10.2.6 AstraZeneca Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Basic Information
10.3.2 Bristol-Myers Squibb Immuno-oncology Therapy Product Overview
10.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Product Market Performance
10.3.4 Bristol-Myers Squibb Business Overview
10.3.5 Bristol-Myers Squibb SWOT Analysis
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 Eli-Lilly
10.4.1 Eli-Lilly Basic Information
10.4.2 Eli-Lilly Immuno-oncology Therapy Product Overview
10.4.3 Eli-Lilly Immuno-oncology Therapy Product Market Performance
10.4.4 Eli-Lilly Business Overview
10.4.5 Eli-Lilly Recent Developments
10.5 Roche
10.5.1 Roche Basic Information
10.5.2 Roche Immuno-oncology Therapy Product Overview
10.5.3 Roche Immuno-oncology Therapy Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Basic Information
10.6.2 GlaxoSmithKline Immuno-oncology Therapy Product Overview
10.6.3 GlaxoSmithKline Immuno-oncology Therapy Product Market Performance
10.6.4 GlaxoSmithKline Business Overview
10.6.5 GlaxoSmithKline Recent Developments
10.7 Janssen Biotech
10.7.1 Janssen Biotech Basic Information
10.7.2 Janssen Biotech Immuno-oncology Therapy Product Overview
10.7.3 Janssen Biotech Immuno-oncology Therapy Product Market Performance
10.7.4 Janssen Biotech Business Overview
10.7.5 Janssen Biotech Recent Developments
10.8 Merck
10.8.1 Merck Basic Information
10.8.2 Merck Immuno-oncology Therapy Product Overview
10.8.3 Merck Immuno-oncology Therapy Product Market Performance
10.8.4 Merck Business Overview
10.8.5 Merck Recent Developments
10.9 Novartis
10.9.1 Novartis Basic Information
10.9.2 Novartis Immuno-oncology Therapy Product Overview
10.9.3 Novartis Immuno-oncology Therapy Product Market Performance
10.9.4 Novartis Business Overview
10.9.5 Novartis Recent Developments
10.10 Pfizer
10.10.1 Pfizer Basic Information
10.10.2 Pfizer Immuno-oncology Therapy Product Overview
10.10.3 Pfizer Immuno-oncology Therapy Product Market Performance
10.10.4 Pfizer Business Overview
10.10.5 Pfizer Recent Developments
10.11 Sanofi
10.11.1 Sanofi Basic Information
10.11.2 Sanofi Immuno-oncology Therapy Product Overview
10.11.3 Sanofi Immuno-oncology Therapy Product Market Performance
10.11.4 Sanofi Business Overview
10.11.5 Sanofi Recent Developments
10.12 Spectrum Pharmaceuticals
10.12.1 Spectrum Pharmaceuticals Basic Information
10.12.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Overview
10.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Market Performance
10.12.4 Spectrum Pharmaceuticals Business Overview
10.12.5 Spectrum Pharmaceuticals Recent Developments
10.13 Takeda
10.13.1 Takeda Basic Information
10.13.2 Takeda Immuno-oncology Therapy Product Overview
10.13.3 Takeda Immuno-oncology Therapy Product Market Performance
10.13.4 Takeda Business Overview
10.13.5 Takeda Recent Developments
10.14 BioNTech SE
10.14.1 BioNTech SE Basic Information
10.14.2 BioNTech SE Immuno-oncology Therapy Product Overview
10.14.3 BioNTech SE Immuno-oncology Therapy Product Market Performance
10.14.4 BioNTech SE Business Overview
10.14.5 BioNTech SE Recent Developments
10.15 Allogene Therapeutics
10.15.1 Allogene Therapeutics Basic Information
10.15.2 Allogene Therapeutics Immuno-oncology Therapy Product Overview
10.15.3 Allogene Therapeutics Immuno-oncology Therapy Product Market Performance
10.15.4 Allogene Therapeutics Business Overview
10.15.5 Allogene Therapeutics Recent Developments
10.16 IMAB-I-Mab Biopharma Co., Ltd.
10.16.1 IMAB-I-Mab Biopharma Co., Ltd. Basic Information
10.16.2 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Overview
10.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Market Performance
10.16.4 IMAB-I-Mab Biopharma Co., Ltd. Business Overview
10.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
10.17 Arcus Biosciences
10.17.1 Arcus Biosciences Basic Information
10.17.2 Arcus Biosciences Immuno-oncology Therapy Product Overview
10.17.3 Arcus Biosciences Immuno-oncology Therapy Product Market Performance
10.17.4 Arcus Biosciences Business Overview
10.17.5 Arcus Biosciences Recent Developments
10.18 Gritstone Oncology
10.18.1 Gritstone Oncology Basic Information
10.18.2 Gritstone Oncology Immuno-oncology Therapy Product Overview
10.18.3 Gritstone Oncology Immuno-oncology Therapy Product Market Performance
10.18.4 Gritstone Oncology Business Overview
10.18.5 Gritstone Oncology Recent Developments
10.19 Autolus Therapeutics
10.19.1 Autolus Therapeutics Basic Information
10.19.2 Autolus Therapeutics Immuno-oncology Therapy Product Overview
10.19.3 Autolus Therapeutics Immuno-oncology Therapy Product Market Performance
10.19.4 Autolus Therapeutics Business Overview
10.19.5 Autolus Therapeutics Recent Developments
10.20 Rubius Therapeutics
10.20.1 Rubius Therapeutics Basic Information
10.20.2 Rubius Therapeutics Immuno-oncology Therapy Product Overview
10.20.3 Rubius Therapeutics Immuno-oncology Therapy Product Market Performance
10.20.4 Rubius Therapeutics Business Overview
10.20.5 Rubius Therapeutics Recent Developments
11 IMMUNO-ONCOLOGY THERAPY MARKET FORECAST BY REGION
11.1 Global Immuno-oncology Therapy Market Size Forecast
11.2 Global Immuno-oncology Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Immuno-oncology Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Immuno-oncology Therapy Market Size Forecast by Region
11.2.4 South America Immuno-oncology Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Immuno-oncology Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Immuno-oncology Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Immuno-oncology Therapy by Type (2026-2035)
12.1.2 Global Immuno-oncology Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Immuno-oncology Therapy by Type (2026-2035)
12.2 Global Immuno-oncology Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Immuno-oncology Therapy Sales (K MT) Forecast by Application
12.2.2 Global Immuno-oncology Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Immuno-oncology Therapy
1.2 Key Market Segments
1.2.1 Immuno-oncology Therapy Segment by Type
1.2.2 Immuno-oncology Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 IMMUNO-ONCOLOGY THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Immuno-oncology Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Immuno-oncology Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 IMMUNO-ONCOLOGY THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Immuno-oncology Therapy Product Life Cycle
3.3 Global Immuno-oncology Therapy Sales by Manufacturers (2020-2025)
3.4 Global Immuno-oncology Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Immuno-oncology Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Immuno-oncology Therapy Market Competitive Situation and Trends
3.8.1 Immuno-oncology Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Immuno-oncology Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 IMMUNO-ONCOLOGY THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Immuno-oncology Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF IMMUNO-ONCOLOGY THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Immuno-oncology Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Immuno-oncology Therapy Market
5.7 ESG Ratings of Leading Companies
6 IMMUNO-ONCOLOGY THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno-oncology Therapy Sales Market Share by Type (2020-2025)
6.3 Global Immuno-oncology Therapy Market Size by Type (2020-2025)
6.4 Global Immuno-oncology Therapy Price by Type (2020-2025)
7 IMMUNO-ONCOLOGY THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno-oncology Therapy Market Sales by Application (2020-2025)
7.3 Global Immuno-oncology Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Immuno-oncology Therapy Sales Growth Rate by Application (2020-2025)
8 IMMUNO-ONCOLOGY THERAPY MARKET SALES BY REGION
8.1 Global Immuno-oncology Therapy Sales by Region
8.1.1 Global Immuno-oncology Therapy Sales by Region
8.1.2 Global Immuno-oncology Therapy Sales Market Share by Region
8.2 Global Immuno-oncology Therapy Market Size by Region
8.2.1 Global Immuno-oncology Therapy Market Size by Region
8.2.2 Global Immuno-oncology Therapy Market Size by Region
8.3 North America
8.3.1 North America Immuno-oncology Therapy Sales by Country
8.3.2 North America Immuno-oncology Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Immuno-oncology Therapy Sales by Country
8.4.2 Europe Immuno-oncology Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Immuno-oncology Therapy Sales by Region
8.5.2 Asia Pacific Immuno-oncology Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Immuno-oncology Therapy Sales by Country
8.6.2 South America Immuno-oncology Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Immuno-oncology Therapy Sales by Region
8.7.2 Middle East and Africa Immuno-oncology Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 IMMUNO-ONCOLOGY THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Immuno-oncology Therapy by Region(2020-2025)
9.2 Global Immuno-oncology Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Immuno-oncology Therapy Production
9.4.1 North America Immuno-oncology Therapy Production Growth Rate (2020-2025)
9.4.2 North America Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Immuno-oncology Therapy Production
9.5.1 Europe Immuno-oncology Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Immuno-oncology Therapy Production (2020-2025)
9.6.1 Japan Immuno-oncology Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Immuno-oncology Therapy Production (2020-2025)
9.7.1 China Immuno-oncology Therapy Production Growth Rate (2020-2025)
9.7.2 China Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Amgen
10.1.1 Amgen Basic Information
10.1.2 Amgen Immuno-oncology Therapy Product Overview
10.1.3 Amgen Immuno-oncology Therapy Product Market Performance
10.1.4 Amgen Business Overview
10.1.5 Amgen SWOT Analysis
10.1.6 Amgen Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Basic Information
10.2.2 AstraZeneca Immuno-oncology Therapy Product Overview
10.2.3 AstraZeneca Immuno-oncology Therapy Product Market Performance
10.2.4 AstraZeneca Business Overview
10.2.5 AstraZeneca SWOT Analysis
10.2.6 AstraZeneca Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Basic Information
10.3.2 Bristol-Myers Squibb Immuno-oncology Therapy Product Overview
10.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Product Market Performance
10.3.4 Bristol-Myers Squibb Business Overview
10.3.5 Bristol-Myers Squibb SWOT Analysis
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 Eli-Lilly
10.4.1 Eli-Lilly Basic Information
10.4.2 Eli-Lilly Immuno-oncology Therapy Product Overview
10.4.3 Eli-Lilly Immuno-oncology Therapy Product Market Performance
10.4.4 Eli-Lilly Business Overview
10.4.5 Eli-Lilly Recent Developments
10.5 Roche
10.5.1 Roche Basic Information
10.5.2 Roche Immuno-oncology Therapy Product Overview
10.5.3 Roche Immuno-oncology Therapy Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Basic Information
10.6.2 GlaxoSmithKline Immuno-oncology Therapy Product Overview
10.6.3 GlaxoSmithKline Immuno-oncology Therapy Product Market Performance
10.6.4 GlaxoSmithKline Business Overview
10.6.5 GlaxoSmithKline Recent Developments
10.7 Janssen Biotech
10.7.1 Janssen Biotech Basic Information
10.7.2 Janssen Biotech Immuno-oncology Therapy Product Overview
10.7.3 Janssen Biotech Immuno-oncology Therapy Product Market Performance
10.7.4 Janssen Biotech Business Overview
10.7.5 Janssen Biotech Recent Developments
10.8 Merck
10.8.1 Merck Basic Information
10.8.2 Merck Immuno-oncology Therapy Product Overview
10.8.3 Merck Immuno-oncology Therapy Product Market Performance
10.8.4 Merck Business Overview
10.8.5 Merck Recent Developments
10.9 Novartis
10.9.1 Novartis Basic Information
10.9.2 Novartis Immuno-oncology Therapy Product Overview
10.9.3 Novartis Immuno-oncology Therapy Product Market Performance
10.9.4 Novartis Business Overview
10.9.5 Novartis Recent Developments
10.10 Pfizer
10.10.1 Pfizer Basic Information
10.10.2 Pfizer Immuno-oncology Therapy Product Overview
10.10.3 Pfizer Immuno-oncology Therapy Product Market Performance
10.10.4 Pfizer Business Overview
10.10.5 Pfizer Recent Developments
10.11 Sanofi
10.11.1 Sanofi Basic Information
10.11.2 Sanofi Immuno-oncology Therapy Product Overview
10.11.3 Sanofi Immuno-oncology Therapy Product Market Performance
10.11.4 Sanofi Business Overview
10.11.5 Sanofi Recent Developments
10.12 Spectrum Pharmaceuticals
10.12.1 Spectrum Pharmaceuticals Basic Information
10.12.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Overview
10.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Market Performance
10.12.4 Spectrum Pharmaceuticals Business Overview
10.12.5 Spectrum Pharmaceuticals Recent Developments
10.13 Takeda
10.13.1 Takeda Basic Information
10.13.2 Takeda Immuno-oncology Therapy Product Overview
10.13.3 Takeda Immuno-oncology Therapy Product Market Performance
10.13.4 Takeda Business Overview
10.13.5 Takeda Recent Developments
10.14 BioNTech SE
10.14.1 BioNTech SE Basic Information
10.14.2 BioNTech SE Immuno-oncology Therapy Product Overview
10.14.3 BioNTech SE Immuno-oncology Therapy Product Market Performance
10.14.4 BioNTech SE Business Overview
10.14.5 BioNTech SE Recent Developments
10.15 Allogene Therapeutics
10.15.1 Allogene Therapeutics Basic Information
10.15.2 Allogene Therapeutics Immuno-oncology Therapy Product Overview
10.15.3 Allogene Therapeutics Immuno-oncology Therapy Product Market Performance
10.15.4 Allogene Therapeutics Business Overview
10.15.5 Allogene Therapeutics Recent Developments
10.16 IMAB-I-Mab Biopharma Co., Ltd.
10.16.1 IMAB-I-Mab Biopharma Co., Ltd. Basic Information
10.16.2 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Overview
10.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Market Performance
10.16.4 IMAB-I-Mab Biopharma Co., Ltd. Business Overview
10.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
10.17 Arcus Biosciences
10.17.1 Arcus Biosciences Basic Information
10.17.2 Arcus Biosciences Immuno-oncology Therapy Product Overview
10.17.3 Arcus Biosciences Immuno-oncology Therapy Product Market Performance
10.17.4 Arcus Biosciences Business Overview
10.17.5 Arcus Biosciences Recent Developments
10.18 Gritstone Oncology
10.18.1 Gritstone Oncology Basic Information
10.18.2 Gritstone Oncology Immuno-oncology Therapy Product Overview
10.18.3 Gritstone Oncology Immuno-oncology Therapy Product Market Performance
10.18.4 Gritstone Oncology Business Overview
10.18.5 Gritstone Oncology Recent Developments
10.19 Autolus Therapeutics
10.19.1 Autolus Therapeutics Basic Information
10.19.2 Autolus Therapeutics Immuno-oncology Therapy Product Overview
10.19.3 Autolus Therapeutics Immuno-oncology Therapy Product Market Performance
10.19.4 Autolus Therapeutics Business Overview
10.19.5 Autolus Therapeutics Recent Developments
10.20 Rubius Therapeutics
10.20.1 Rubius Therapeutics Basic Information
10.20.2 Rubius Therapeutics Immuno-oncology Therapy Product Overview
10.20.3 Rubius Therapeutics Immuno-oncology Therapy Product Market Performance
10.20.4 Rubius Therapeutics Business Overview
10.20.5 Rubius Therapeutics Recent Developments
11 IMMUNO-ONCOLOGY THERAPY MARKET FORECAST BY REGION
11.1 Global Immuno-oncology Therapy Market Size Forecast
11.2 Global Immuno-oncology Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Immuno-oncology Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Immuno-oncology Therapy Market Size Forecast by Region
11.2.4 South America Immuno-oncology Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Immuno-oncology Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Immuno-oncology Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Immuno-oncology Therapy by Type (2026-2035)
12.1.2 Global Immuno-oncology Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Immuno-oncology Therapy by Type (2026-2035)
12.2 Global Immuno-oncology Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Immuno-oncology Therapy Sales (K MT) Forecast by Application
12.2.2 Global Immuno-oncology Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Immuno-oncology Therapy Market Size by Type (M USD)
Table 4. Global Immuno-oncology Therapy Market Size by Application
Table 5. Immuno-oncology Therapy Market Size Comparison by Region (M USD)
Table 6. Global Immuno-oncology Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Immuno-oncology Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Immuno-oncology Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Immuno-oncology Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Therapy as of 2025)
Table 11. Global Market Immuno-oncology Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Immuno-oncology Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immuno-oncology Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Immuno-oncology Therapy Sales by Type (K MT)
Table 27. Global Immuno-oncology Therapy Market Size by Type (M USD)
Table 28. Global Immuno-oncology Therapy Sales (K MT) by Type (2020-2025)
Table 29. Global Immuno-oncology Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Immuno-oncology Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Immuno-oncology Therapy Market Share by Type (2020-2025)
Table 32. Global Immuno-oncology Therapy Price (USD/KG) by Type (2020-2025)
Table 33. Global Immuno-oncology Therapy Sales (K MT) by Application
Table 34. Global Immuno-oncology Therapy Market Size by Application
Table 35. Global Immuno-oncology Therapy Sales by Application (2020-2025) & (K MT)
Table 36. Global Immuno-oncology Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Immuno-oncology Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Immuno-oncology Therapy Market Share by Application (2020-2025)
Table 39. Global Immuno-oncology Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Immuno-oncology Therapy Sales by Region (2020-2025) & (K MT)
Table 41. Global Immuno-oncology Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Immuno-oncology Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Immuno-oncology Therapy Market Size by Region (2020-2025)
Table 44. North America Immuno-oncology Therapy Sales by Country (2020-2025) & (K MT)
Table 45. North America Immuno-oncology Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Immuno-oncology Therapy Sales by Country (2020-2025) & (K MT)
Table 47. Europe Immuno-oncology Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Immuno-oncology Therapy Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Immuno-oncology Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Immuno-oncology Therapy Sales by Country (2020-2025) & (K MT)
Table 51. South America Immuno-oncology Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Immuno-oncology Therapy Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Immuno-oncology Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Immuno-oncology Therapy Production (K MT) by Region(2020-2025)
Table 55. Global Immuno-oncology Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Immuno-oncology Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Amgen Basic Information
Table 63. Amgen Immuno-oncology Therapy Product Overview
Table 64. Amgen Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Amgen Business Overview
Table 66. Amgen SWOT Analysis
Table 67. Amgen Recent Developments
Table 68. AstraZeneca Basic Information
Table 69. AstraZeneca Immuno-oncology Therapy Product Overview
Table 70. AstraZeneca Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. AstraZeneca Business Overview
Table 72. AstraZeneca SWOT Analysis
Table 73. AstraZeneca Recent Developments
Table 74. Bristol-Myers Squibb Basic Information
Table 75. Bristol-Myers Squibb Immuno-oncology Therapy Product Overview
Table 76. Bristol-Myers Squibb Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb SWOT Analysis
Table 79. Bristol-Myers Squibb Recent Developments
Table 80. Eli-Lilly Basic Information
Table 81. Eli-Lilly Immuno-oncology Therapy Product Overview
Table 82. Eli-Lilly Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Eli-Lilly Business Overview
Table 84. Eli-Lilly Recent Developments
Table 85. Roche Basic Information
Table 86. Roche Immuno-oncology Therapy Product Overview
Table 87. Roche Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Roche Business Overview
Table 89. Roche Recent Developments
Table 90. GlaxoSmithKline Basic Information
Table 91. GlaxoSmithKline Immuno-oncology Therapy Product Overview
Table 92. GlaxoSmithKline Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. GlaxoSmithKline Business Overview
Table 94. GlaxoSmithKline Recent Developments
Table 95. Janssen Biotech Basic Information
Table 96. Janssen Biotech Immuno-oncology Therapy Product Overview
Table 97. Janssen Biotech Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Janssen Biotech Business Overview
Table 99. Janssen Biotech Recent Developments
Table 100. Merck Basic Information
Table 101. Merck Immuno-oncology Therapy Product Overview
Table 102. Merck Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Merck Business Overview
Table 104. Merck Recent Developments
Table 105. Novartis Basic Information
Table 106. Novartis Immuno-oncology Therapy Product Overview
Table 107. Novartis Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Novartis Business Overview
Table 109. Novartis Recent Developments
Table 110. Pfizer Basic Information
Table 111. Pfizer Immuno-oncology Therapy Product Overview
Table 112. Pfizer Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Pfizer Business Overview
Table 114. Pfizer Recent Developments
Table 115. Sanofi Basic Information
Table 116. Sanofi Immuno-oncology Therapy Product Overview
Table 117. Sanofi Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Sanofi Business Overview
Table 119. Sanofi Recent Developments
Table 120. Spectrum Pharmaceuticals Basic Information
Table 121. Spectrum Pharmaceuticals Immuno-oncology Therapy Product Overview
Table 122. Spectrum Pharmaceuticals Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Spectrum Pharmaceuticals Business Overview
Table 124. Spectrum Pharmaceuticals Recent Developments
Table 125. Takeda Basic Information
Table 126. Takeda Immuno-oncology Therapy Product Overview
Table 127. Takeda Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Takeda Business Overview
Table 129. Takeda Recent Developments
Table 130. BioNTech SE Basic Information
Table 131. BioNTech SE Immuno-oncology Therapy Product Overview
Table 132. BioNTech SE Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. BioNTech SE Business Overview
Table 134. BioNTech SE Recent Developments
Table 135. Allogene Therapeutics Basic Information
Table 136. Allogene Therapeutics Immuno-oncology Therapy Product Overview
Table 137. Allogene Therapeutics Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Allogene Therapeutics Business Overview
Table 139. Allogene Therapeutics Recent Developments
Table 140. IMAB-I-Mab Biopharma Co., Ltd. Basic Information
Table 141. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Overview
Table 142. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. IMAB-I-Mab Biopharma Co., Ltd. Business Overview
Table 144. IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
Table 145. Arcus Biosciences Basic Information
Table 146. Arcus Biosciences Immuno-oncology Therapy Product Overview
Table 147. Arcus Biosciences Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Arcus Biosciences Business Overview
Table 149. Arcus Biosciences Recent Developments
Table 150. Gritstone Oncology Basic Information
Table 151. Gritstone Oncology Immuno-oncology Therapy Product Overview
Table 152. Gritstone Oncology Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Gritstone Oncology Business Overview
Table 154. Gritstone Oncology Recent Developments
Table 155. Autolus Therapeutics Basic Information
Table 156. Autolus Therapeutics Immuno-oncology Therapy Product Overview
Table 157. Autolus Therapeutics Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Autolus Therapeutics Business Overview
Table 159. Autolus Therapeutics Recent Developments
Table 160. Rubius Therapeutics Basic Information
Table 161. Rubius Therapeutics Immuno-oncology Therapy Product Overview
Table 162. Rubius Therapeutics Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Rubius Therapeutics Business Overview
Table 164. Rubius Therapeutics Recent Developments
Table 165. Global Immuno-oncology Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Immuno-oncology Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Immuno-oncology Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Immuno-oncology Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Immuno-oncology Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Immuno-oncology Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Immuno-oncology Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Immuno-oncology Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Immuno-oncology Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Immuno-oncology Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Immuno-oncology Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Immuno-oncology Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Immuno-oncology Therapy Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Immuno-oncology Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Immuno-oncology Therapy Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Immuno-oncology Therapy Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Immuno-oncology Therapy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Immuno-oncology Therapy Market Size by Type (M USD)
Table 4. Global Immuno-oncology Therapy Market Size by Application
Table 5. Immuno-oncology Therapy Market Size Comparison by Region (M USD)
Table 6. Global Immuno-oncology Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Immuno-oncology Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Immuno-oncology Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Immuno-oncology Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Therapy as of 2025)
Table 11. Global Market Immuno-oncology Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Immuno-oncology Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immuno-oncology Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Immuno-oncology Therapy Sales by Type (K MT)
Table 27. Global Immuno-oncology Therapy Market Size by Type (M USD)
Table 28. Global Immuno-oncology Therapy Sales (K MT) by Type (2020-2025)
Table 29. Global Immuno-oncology Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Immuno-oncology Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Immuno-oncology Therapy Market Share by Type (2020-2025)
Table 32. Global Immuno-oncology Therapy Price (USD/KG) by Type (2020-2025)
Table 33. Global Immuno-oncology Therapy Sales (K MT) by Application
Table 34. Global Immuno-oncology Therapy Market Size by Application
Table 35. Global Immuno-oncology Therapy Sales by Application (2020-2025) & (K MT)
Table 36. Global Immuno-oncology Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Immuno-oncology Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Immuno-oncology Therapy Market Share by Application (2020-2025)
Table 39. Global Immuno-oncology Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Immuno-oncology Therapy Sales by Region (2020-2025) & (K MT)
Table 41. Global Immuno-oncology Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Immuno-oncology Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Immuno-oncology Therapy Market Size by Region (2020-2025)
Table 44. North America Immuno-oncology Therapy Sales by Country (2020-2025) & (K MT)
Table 45. North America Immuno-oncology Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Immuno-oncology Therapy Sales by Country (2020-2025) & (K MT)
Table 47. Europe Immuno-oncology Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Immuno-oncology Therapy Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Immuno-oncology Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Immuno-oncology Therapy Sales by Country (2020-2025) & (K MT)
Table 51. South America Immuno-oncology Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Immuno-oncology Therapy Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Immuno-oncology Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Immuno-oncology Therapy Production (K MT) by Region(2020-2025)
Table 55. Global Immuno-oncology Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Immuno-oncology Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Amgen Basic Information
Table 63. Amgen Immuno-oncology Therapy Product Overview
Table 64. Amgen Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Amgen Business Overview
Table 66. Amgen SWOT Analysis
Table 67. Amgen Recent Developments
Table 68. AstraZeneca Basic Information
Table 69. AstraZeneca Immuno-oncology Therapy Product Overview
Table 70. AstraZeneca Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. AstraZeneca Business Overview
Table 72. AstraZeneca SWOT Analysis
Table 73. AstraZeneca Recent Developments
Table 74. Bristol-Myers Squibb Basic Information
Table 75. Bristol-Myers Squibb Immuno-oncology Therapy Product Overview
Table 76. Bristol-Myers Squibb Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb SWOT Analysis
Table 79. Bristol-Myers Squibb Recent Developments
Table 80. Eli-Lilly Basic Information
Table 81. Eli-Lilly Immuno-oncology Therapy Product Overview
Table 82. Eli-Lilly Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Eli-Lilly Business Overview
Table 84. Eli-Lilly Recent Developments
Table 85. Roche Basic Information
Table 86. Roche Immuno-oncology Therapy Product Overview
Table 87. Roche Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Roche Business Overview
Table 89. Roche Recent Developments
Table 90. GlaxoSmithKline Basic Information
Table 91. GlaxoSmithKline Immuno-oncology Therapy Product Overview
Table 92. GlaxoSmithKline Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. GlaxoSmithKline Business Overview
Table 94. GlaxoSmithKline Recent Developments
Table 95. Janssen Biotech Basic Information
Table 96. Janssen Biotech Immuno-oncology Therapy Product Overview
Table 97. Janssen Biotech Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Janssen Biotech Business Overview
Table 99. Janssen Biotech Recent Developments
Table 100. Merck Basic Information
Table 101. Merck Immuno-oncology Therapy Product Overview
Table 102. Merck Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Merck Business Overview
Table 104. Merck Recent Developments
Table 105. Novartis Basic Information
Table 106. Novartis Immuno-oncology Therapy Product Overview
Table 107. Novartis Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Novartis Business Overview
Table 109. Novartis Recent Developments
Table 110. Pfizer Basic Information
Table 111. Pfizer Immuno-oncology Therapy Product Overview
Table 112. Pfizer Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Pfizer Business Overview
Table 114. Pfizer Recent Developments
Table 115. Sanofi Basic Information
Table 116. Sanofi Immuno-oncology Therapy Product Overview
Table 117. Sanofi Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Sanofi Business Overview
Table 119. Sanofi Recent Developments
Table 120. Spectrum Pharmaceuticals Basic Information
Table 121. Spectrum Pharmaceuticals Immuno-oncology Therapy Product Overview
Table 122. Spectrum Pharmaceuticals Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Spectrum Pharmaceuticals Business Overview
Table 124. Spectrum Pharmaceuticals Recent Developments
Table 125. Takeda Basic Information
Table 126. Takeda Immuno-oncology Therapy Product Overview
Table 127. Takeda Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Takeda Business Overview
Table 129. Takeda Recent Developments
Table 130. BioNTech SE Basic Information
Table 131. BioNTech SE Immuno-oncology Therapy Product Overview
Table 132. BioNTech SE Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. BioNTech SE Business Overview
Table 134. BioNTech SE Recent Developments
Table 135. Allogene Therapeutics Basic Information
Table 136. Allogene Therapeutics Immuno-oncology Therapy Product Overview
Table 137. Allogene Therapeutics Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Allogene Therapeutics Business Overview
Table 139. Allogene Therapeutics Recent Developments
Table 140. IMAB-I-Mab Biopharma Co., Ltd. Basic Information
Table 141. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Overview
Table 142. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. IMAB-I-Mab Biopharma Co., Ltd. Business Overview
Table 144. IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
Table 145. Arcus Biosciences Basic Information
Table 146. Arcus Biosciences Immuno-oncology Therapy Product Overview
Table 147. Arcus Biosciences Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Arcus Biosciences Business Overview
Table 149. Arcus Biosciences Recent Developments
Table 150. Gritstone Oncology Basic Information
Table 151. Gritstone Oncology Immuno-oncology Therapy Product Overview
Table 152. Gritstone Oncology Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Gritstone Oncology Business Overview
Table 154. Gritstone Oncology Recent Developments
Table 155. Autolus Therapeutics Basic Information
Table 156. Autolus Therapeutics Immuno-oncology Therapy Product Overview
Table 157. Autolus Therapeutics Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Autolus Therapeutics Business Overview
Table 159. Autolus Therapeutics Recent Developments
Table 160. Rubius Therapeutics Basic Information
Table 161. Rubius Therapeutics Immuno-oncology Therapy Product Overview
Table 162. Rubius Therapeutics Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Rubius Therapeutics Business Overview
Table 164. Rubius Therapeutics Recent Developments
Table 165. Global Immuno-oncology Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Immuno-oncology Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Immuno-oncology Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Immuno-oncology Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Immuno-oncology Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Immuno-oncology Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Immuno-oncology Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Immuno-oncology Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Immuno-oncology Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Immuno-oncology Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Immuno-oncology Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Immuno-oncology Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Immuno-oncology Therapy Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Immuno-oncology Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Immuno-oncology Therapy Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Immuno-oncology Therapy Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Immuno-oncology Therapy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Immuno-oncology Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immuno-oncology Therapy Market Size (M USD), 2025-2035
Figure 5. Global Immuno-oncology Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Immuno-oncology Therapy Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immuno-oncology Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Immuno-oncology Therapy Product Life Cycle
Figure 13. Immuno-oncology Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Immuno-oncology Therapy Revenue Share by Manufacturers in 2025
Figure 15. Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Immuno-oncology Therapy Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Immuno-oncology Therapy Revenue in 2025
Figure 18. Industry Chain Map of Immuno-oncology Therapy
Figure 19. Global Immuno-oncology Therapy Market PEST Analysis
Figure 20. Global Immuno-oncology Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Immuno-oncology Therapy Market Share by Type
Figure 27. Sales Market Share of Immuno-oncology Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Immuno-oncology Therapy by Type in 2025
Figure 29. Market Share of Immuno-oncology Therapy by Type (2020-2025)
Figure 30. Market Share of Immuno-oncology Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Immuno-oncology Therapy Market Share by Application
Figure 33. Global Immuno-oncology Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Immuno-oncology Therapy Sales Market Share by Application in 2025
Figure 35. Global Immuno-oncology Therapy Market Share by Application (2020-2025)
Figure 36. Global Immuno-oncology Therapy Market Share by Application in 2025
Figure 37. Global Immuno-oncology Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Immuno-oncology Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Immuno-oncology Therapy Market Size by Region (2020-2025)
Figure 40. North America Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Immuno-oncology Therapy Sales Market Share by Country in 2024
Figure 43. North America Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Immuno-oncology Therapy Market Size by Country in 2024
Figure 45. U.S. Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Immuno-oncology Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Immuno-oncology Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Immuno-oncology Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Immuno-oncology Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Immuno-oncology Therapy Sales Market Share by Country in 2024
Figure 53. Europe Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Immuno-oncology Therapy Market Size by Country in 2024
Figure 55. Germany Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Immuno-oncology Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Immuno-oncology Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Immuno-oncology Therapy Market Size by Region in 2024
Figure 68. China Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Immuno-oncology Therapy Sales and Growth Rate (K MT)
Figure 79. South America Immuno-oncology Therapy Sales Market Share by Country in 2024
Figure 80. South America Immuno-oncology Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Immuno-oncology Therapy Market Size by Country in 2024
Figure 82. Brazil Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Immuno-oncology Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Immuno-oncology Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Immuno-oncology Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Immuno-oncology Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Immuno-oncology Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Immuno-oncology Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Immuno-oncology Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Immuno-oncology Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China Immuno-oncology Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Immuno-oncology Therapy Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Immuno-oncology Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Immuno-oncology Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Immuno-oncology Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Immuno-oncology Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Immuno-oncology Therapy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Immuno-oncology Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immuno-oncology Therapy Market Size (M USD), 2025-2035
Figure 5. Global Immuno-oncology Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Immuno-oncology Therapy Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immuno-oncology Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Immuno-oncology Therapy Product Life Cycle
Figure 13. Immuno-oncology Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Immuno-oncology Therapy Revenue Share by Manufacturers in 2025
Figure 15. Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Immuno-oncology Therapy Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Immuno-oncology Therapy Revenue in 2025
Figure 18. Industry Chain Map of Immuno-oncology Therapy
Figure 19. Global Immuno-oncology Therapy Market PEST Analysis
Figure 20. Global Immuno-oncology Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Immuno-oncology Therapy Market Share by Type
Figure 27. Sales Market Share of Immuno-oncology Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Immuno-oncology Therapy by Type in 2025
Figure 29. Market Share of Immuno-oncology Therapy by Type (2020-2025)
Figure 30. Market Share of Immuno-oncology Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Immuno-oncology Therapy Market Share by Application
Figure 33. Global Immuno-oncology Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Immuno-oncology Therapy Sales Market Share by Application in 2025
Figure 35. Global Immuno-oncology Therapy Market Share by Application (2020-2025)
Figure 36. Global Immuno-oncology Therapy Market Share by Application in 2025
Figure 37. Global Immuno-oncology Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Immuno-oncology Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Immuno-oncology Therapy Market Size by Region (2020-2025)
Figure 40. North America Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Immuno-oncology Therapy Sales Market Share by Country in 2024
Figure 43. North America Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Immuno-oncology Therapy Market Size by Country in 2024
Figure 45. U.S. Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Immuno-oncology Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Immuno-oncology Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Immuno-oncology Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Immuno-oncology Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Immuno-oncology Therapy Sales Market Share by Country in 2024
Figure 53. Europe Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Immuno-oncology Therapy Market Size by Country in 2024
Figure 55. Germany Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Immuno-oncology Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Immuno-oncology Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Immuno-oncology Therapy Market Size by Region in 2024
Figure 68. China Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Immuno-oncology Therapy Sales and Growth Rate (K MT)
Figure 79. South America Immuno-oncology Therapy Sales Market Share by Country in 2024
Figure 80. South America Immuno-oncology Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Immuno-oncology Therapy Market Size by Country in 2024
Figure 82. Brazil Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Immuno-oncology Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Immuno-oncology Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Immuno-oncology Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Immuno-oncology Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Immuno-oncology Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Immuno-oncology Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Immuno-oncology Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Immuno-oncology Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Immuno-oncology Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Immuno-oncology Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China Immuno-oncology Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Immuno-oncology Therapy Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Immuno-oncology Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Immuno-oncology Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Immuno-oncology Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Immuno-oncology Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Immuno-oncology Therapy Market Share Forecast by Application (2026-2035)
